高级检索
当前位置: 首页 > 详情页

Circular RNA circFARSA promotes the tumorigenesis of non-small cell lung cancer by elevating B7H3 via sponging miR-15a-5p

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Kunming Univ Sci & Technol, Affiliated Hosp, Peoples Hosp Yunnan Prov 1, Dept Pulm & Crit Care Med, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China [2]Shenzhen Univ, Coll Life Sci & Oceanog, Vasc Dis Res Ctr, Shenzhen 518060, Peoples R China
出处:
ISSN:

关键词: lung cancer circFARSA miR-15a-5p proliferation metastasis

摘要:
Non-small cell lung cancer (NSCLC) is currently one of the malignant tumors with the highest incidence and mortality rate in China. Circular RNA hsa_circ_0000896 (circFARSA) has been reported as being an oncogene and a potential biomarker for NSCL. However, the functional role and action mechanism of circFARSA in NSCLC progression have not been fully elucidated. The present study demonstrated that circFRASA was upregulated in NSCLC tissues and cell lines, and its expression was positively correlated with poor prognosis of patients with NSCLC. Further experiments revealed that circFARSA knockdown inhibited cell proliferation, migration, and invasion in vitro experiments, but overexpression of circFARSA exhibited opposite results. Mechanistically, circFARSA facilitated the malignant phenotype of NSCLC cells by enhancing B7H3 expression through sponging miR-15a-5p. In vivo experiments, knockdown of circFARSA restricted tumor growth and metastasis. In conclusion, circFARSA served as a sponge of miR-15a-5p to promote tumorigenesis and development of NSCLC by upregulation of B7H3 expression, which provided evidence of circFARSA maybe act as a novel therapeutic target for NSCLC.

基金:

基金编号: 81660012 81970053 81570046 91739109 2021LCZXXF-HX09 KHBS-2022-030 202201AY070001-224 202201AY070001-224 202102AA100057 ZX2019-01-03 2019IC032-1

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 3 区 生物学
小类 | 4 区 细胞生物学
最新[2023]版:
大类 | 3 区 生物学
小类 | 4 区 细胞生物学
JCR分区:
出版当年[2021]版:
Q2 CELL BIOLOGY
最新[2023]版:
Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Kunming Univ Sci & Technol, Affiliated Hosp, Peoples Hosp Yunnan Prov 1, Dept Pulm & Crit Care Med, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Kunming Univ Sci & Technol, Affiliated Hosp, Peoples Hosp Yunnan Prov 1, Dept Pulm & Crit Care Med, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China [2]Shenzhen Univ, Coll Life Sci & Oceanog, Vasc Dis Res Ctr, Shenzhen 518060, Peoples R China [*1]Department of Pulmonary and Critical Care Medicine, The First People’s Hospital of Yunnan Province. The Affiliated Hospital of Kunming University of Science and Technology, No. 157 Jinbi Road, Xishan District, Kunming, 650032, China [*2]Vascular Disease Research Center, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, 518060, Guangdong, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82490 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号